ACE2 and neoplasm: Reduced ACE2 expression was linked to unfavourable tumour phenotype in colorectal adenocarcinoma and in clear cell renal cell carcinoma and linked to reduced recurrence-free survival in clear cell renal cell carcinoma (p = 0.0169; Figure 4A).